BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

Ardigen supports JUMP-CP Consortium to transform drug discovery with Cell Painting technology

The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cel...

October 28, 2022 | News

Merck Highlights New Data for Evobrutinib

Phase II clinical trial data of evobrutinib demonstrated low disease activity and stable EDSS, with NfL levels, a marker of neuronal injury, remaining lo...

October 26, 2022 | News

BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI Worldwide 2022 Conference

CPhI WW will be held in Frankfurt, Germany from November 1 to November 3, 2022. The conference will focus on product sustainability and innovation across t...

October 21, 2022 | News

Bexson Biomedical and Stevanato Group Awarded PDA Drug Delivery Innovation Award

At PDA's annual conference in Palm Springs, CA on October 18th, PDA's leadership presented the award to Bexson Biomedical's Sr. VP of D...

October 20, 2022 | News

Kira Pharmaceuticals Announces IND Approval from Chinese NMPA

Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, announced today th...

October 17, 2022 | News

Merck to Support Jacobio Pharma on Clinical Trial of JAB-21822 in Combination with Cetuximab

This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer. Jacobio ...

October 13, 2022 | News

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW014

Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic dis...

October 10, 2022 | News

Transcenta Received IND Clearance from FDA

Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...

October 05, 2022 | News

Teva Reaches Agreement With Georgia to Settle the State’s Price Fixing Claims

Teva is committed to doing business the right way, in compliance with all applicable laws. Consistent with that commitment, Teva has also agreed, as part o...

October 03, 2022 | News

AeroRx Partners with HCmed to Develop a Nebulized LABA/LAMA Combination Solution

AeroRx Therapeutics, LLC. (AeroRx) and HCmed Innovations Co., Ltd. (HCmed) have initiated a collaboration, introducing a LABA/LAMA combination solution for...

October 03, 2022 | News

First Patient in New Zealand Dosed with Illuccix® - Telix's Prostate Cancer Imaging Agent

As Illuccix rolls out to positron emission tomography (PET) sites across the country, Mercy Radiology in Auckland became the first to administer ...

September 30, 2022 | News

Antibiotics Markets in China: Demand to Grow by 9% by 2031

China's demand for Antibiotics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chine...

September 26, 2022 | News

Qurient Announces Collaboration Agreement with MSD

Q901 is a novel highly selective CDK7 inhibitor Q901 is ready for dose escalation study in the U.S. for the treatment of selected advanced solid tumors ...

September 19, 2022 | News

Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China

Ensifentrine is a first-in-class, dual inhibitor of the enzymes phosphodiesterase 3 and 4 ("PDE3" and "PDE4") combining bronchodilator and anti-inflam...

August 21, 2022 | News

Stay Connected